N. Anthony Coles

Insider Reports History

Entity
Individual
Location
Morris Corp. Center I; Bldg. B; 4 Th Flr., 300 Interpace Parkway, Parsippany, New Jersey
Signature
/s/ Mark Bodenrader, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by N. Anthony Coles:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cerevel Therapeutics Holdings, Inc. Director Restricted Stock Units 46,322 $1.96 M $42.24 Feb 6, 2024 Direct
REGENERON PHARMACEUTICALS, INC. Director Common Stock 1,393 $1.33 M $951.26 Jan 2, 2024 Direct
Cerevel Therapeutics Holdings, Inc. Director Common Stock 25,928 $1.07 M $41.18 Jul 1, 2024 Direct
Cerevel Therapeutics Holdings, Inc. Director Stock Option (Right to Buy) 2,177,417 Jul 1, 2024 Direct
REGENERON PHARMACEUTICALS, INC. Director Non-Qualified Stock Option (right to buy) 1,607 Jan 2, 2024 Direct

Insider Reports Filed by N. Anthony Coles

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CERE Cerevel Therapeutics Holdings, Inc. Jul 1, 2024 3 -942,035 4 Jul 3, 2024 Director
CERE Cerevel Therapeutics Holdings, Inc. Jun 5, 2024 1 0 4 Jun 7, 2024 Director
CERE Cerevel Therapeutics Holdings, Inc. Jun 3, 2024 3 -1,855,520 4 Jun 5, 2024 Director
CERE Cerevel Therapeutics Holdings, Inc. May 10, 2024 3 -1,930,125 4 May 14, 2024 Director
CERE Cerevel Therapeutics Holdings, Inc. Apr 1, 2024 3 -1,941,640 4 Apr 3, 2024 Director
CERE Cerevel Therapeutics Holdings, Inc. Mar 4, 2024 3 -1,875,550 4 Mar 6, 2024 Director
CERE Cerevel Therapeutics Holdings, Inc. Feb 29, 2024 3 -1,882,890 4 Mar 4, 2024 Director
CERE Cerevel Therapeutics Holdings, Inc. Feb 6, 2024 3 -104,110 4 Feb 8, 2024 Director
CERE Cerevel Therapeutics Holdings, Inc. Jan 2, 2024 3 -1,936,815 4 Jan 4, 2024 Director
REGN REGENERON PHARMACEUTICALS, INC. Jan 2, 2024 2 0 4 Jan 4, 2024 Director
CERE Cerevel Therapeutics Holdings, Inc. Nov 14, 2023 3 -493,571 4 Nov 16, 2023 Director
CERE Cerevel Therapeutics Holdings, Inc. Nov 7, 2023 6 -584,955 4 Nov 9, 2023 Director
CERE Cerevel Therapeutics Holdings, Inc. Nov 2, 2023 6 -2,183,697 4 Nov 6, 2023 Director
CERE Cerevel Therapeutics Holdings, Inc. Sep 7, 2023 3 -1,028,415 4 Sep 8, 2023 Director
CERE Cerevel Therapeutics Holdings, Inc. Jul 11, 2023 3 -1,326,340 4 Jul 13, 2023 Director
CERE Cerevel Therapeutics Holdings, Inc. Jun 1, 2023 3 -1,455,070 4 Jun 5, 2023 CEO and Chairperson, Director
CERE Cerevel Therapeutics Holdings, Inc. May 4, 2023 5 -1,398,434 4 May 8, 2023 CEO and Chairperson, Director
CERE Cerevel Therapeutics Holdings, Inc. Apr 11, 2023 3 -1,078,130 4 Apr 13, 2023 CEO and Chairperson, Director
CERE Cerevel Therapeutics Holdings, Inc. Mar 2, 2023 6 -1,180,947 4 Mar 6, 2023 CEO and Chairperson, Director
CERE Cerevel Therapeutics Holdings, Inc. Feb 6, 2023 6 -1,481,401 4 Feb 8, 2023 CEO and Chairperson, Director
CERE Cerevel Therapeutics Holdings, Inc. Jan 5, 2023 4 -1,321,871 4 Jan 6, 2023 CEO and Chairperson, Director
REGN REGENERON PHARMACEUTICALS, INC. Jan 3, 2023 2 0 4 Jan 5, 2023 Director
REGN REGENERON PHARMACEUTICALS, INC. Dec 28, 2022 12 -1,565,412 4 Dec 30, 2022 Director
CERE Cerevel Therapeutics Holdings, Inc. Dec 9, 2022 4 -1,158,300 4 Dec 13, 2022 CEO and Chairperson, Director
REGN REGENERON PHARMACEUTICALS, INC. Sep 6, 2022 13 -1,253,229 4 Sep 8, 2022 Director
CERE Cerevel Therapeutics Holdings, Inc. Feb 9, 2022 1 0 4 Feb 11, 2022 CEO and Chairperson, Director
REGN REGENERON PHARMACEUTICALS, INC. Jan 3, 2022 2 0 4 Jan 5, 2022 Director
REGN REGENERON PHARMACEUTICALS, INC. Sep 15, 2021 17 -3,500,677 4 Sep 17, 2021 Director
REGN REGENERON PHARMACEUTICALS, INC. Aug 17, 2021 6 -1,827,180 4 Aug 19, 2021 Director
REGN REGENERON PHARMACEUTICALS, INC. Aug 13, 2021 3 -559,060 4 Aug 16, 2021 Director